JP2008535800A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535800A5
JP2008535800A5 JP2008501331A JP2008501331A JP2008535800A5 JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5 JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5
Authority
JP
Japan
Prior art keywords
fel
seq
chain
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008501331A
Other languages
English (en)
Japanese (ja)
Other versions
JP5302671B2 (ja
JP2008535800A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/060845 external-priority patent/WO2006097530A2/en
Publication of JP2008535800A publication Critical patent/JP2008535800A/ja
Publication of JP2008535800A5 publication Critical patent/JP2008535800A5/ja
Application granted granted Critical
Publication of JP5302671B2 publication Critical patent/JP5302671B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008501331A 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用 Expired - Fee Related JP5302671B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18
US60/662,918 2005-03-18
PCT/EP2006/060845 WO2006097530A2 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013048847A Division JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Publications (3)

Publication Number Publication Date
JP2008535800A JP2008535800A (ja) 2008-09-04
JP2008535800A5 true JP2008535800A5 (enExample) 2009-05-07
JP5302671B2 JP5302671B2 (ja) 2013-10-02

Family

ID=36843236

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008501331A Expired - Fee Related JP5302671B2 (ja) 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Country Status (19)

Country Link
US (3) US7767212B2 (enExample)
EP (1) EP1868642B1 (enExample)
JP (2) JP5302671B2 (enExample)
KR (1) KR20070112225A (enExample)
CN (2) CN101141979B (enExample)
AU (1) AU2006224529B2 (enExample)
BR (1) BRPI0608455A2 (enExample)
CA (1) CA2599218C (enExample)
CY (1) CY1114171T1 (enExample)
DK (1) DK1868642T3 (enExample)
ES (1) ES2424229T3 (enExample)
IL (1) IL185103A0 (enExample)
MX (1) MX2007011160A (enExample)
NZ (1) NZ561040A (enExample)
PL (1) PL1868642T3 (enExample)
PT (1) PT1868642E (enExample)
RU (1) RU2414239C2 (enExample)
WO (1) WO2006097530A2 (enExample)
ZA (1) ZA200707413B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
AU2003246690B2 (en) * 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
EP1524994B1 (en) * 2002-07-19 2011-04-27 Cytos Biotechnology AG Vaccine compositions containing amyloid beta1-6 antigen arrays
US7767212B2 (en) * 2005-03-18 2010-08-03 Cytos Biotechnology Ag CAT allergen conjugates and uses thereof
US20070184068A1 (en) * 2005-12-14 2007-08-09 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
CN101466720B (zh) 2006-06-12 2013-01-02 赛托斯生物技术公司 向rna噬菌体的病毒样颗粒内包装寡核苷酸的方法
HUE032422T2 (en) 2006-09-29 2017-09-28 Takeda Vaccines Inc Norovirus vaccine preparations
PL2162133T3 (pl) * 2007-07-09 2017-03-31 Nestec S.A. Sposoby zmniejszania alergii wywoływanych przez alergeny środowiskowe
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
SG10201601660YA (en) 2007-09-18 2016-04-28 Takeda Vaccines Inc Method of conferring a protective immune response to norovirus
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
AU2009279456B2 (en) 2008-08-08 2015-02-05 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
WO2011057134A1 (en) * 2009-11-05 2011-05-12 Novici Biotech Llc Generation of antigenic virus-like particles through protein-protein linkages
US8321012B2 (en) * 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
EA029470B1 (ru) 2011-07-11 2018-03-30 Такеда Вэксинс, Инк. Способ стимулирования формирования защитного иммунитета против норовируса
HK1200849A1 (en) 2011-12-22 2015-08-14 F. Hoffmann-La Roche Ag Full length antibody display system for eukaryotic cells and its use
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
WO2014066443A1 (en) * 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
CA2922113C (en) 2013-08-23 2023-05-23 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
MX2016007960A (es) * 2013-12-19 2016-09-09 Nestec Sa Composiciones y metodos para reducir los alegernos de gato en el medio ambiente.
MA40824A (fr) 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
US10526376B2 (en) 2015-01-15 2020-01-07 University Of Copenhagen Virus-like particle with efficient epitope display
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
RU2018105007A (ru) * 2015-09-08 2019-10-10 Университет Цюрих Композиции против аллергии на кошек
DK3368068T3 (da) 2015-10-30 2021-02-22 Univ Copenhagen Viruslignende partikler med effektiv epitopdisplay
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
EP3558347B1 (en) 2016-12-22 2026-01-21 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
MX2021007285A (es) 2018-12-20 2021-09-23 Saiba AG Particulas similares a virus del cmv modificadas por fusion.
KR20240145520A (ko) * 2022-03-18 2024-10-07 덴카 주식회사 링커에 의해 연결된 캡시드 단백질을 포함하는 바이러스 유사입자
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025139524A1 (zh) * 2023-12-28 2025-07-03 江苏众红生物工程创药研究院有限公司 猫重组变应原及其药用组合物、制备方法和应用
WO2025194374A1 (zh) * 2024-03-20 2025-09-25 深圳赫兹生命科学技术有限公司 猫过敏原多肽片段及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
DE68924850T2 (de) * 1988-06-14 1996-10-10 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
EP0563091A1 (en) 1990-12-20 1993-10-06 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccines based on hepatitis b surface antigen
GB9114003D0 (en) * 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
AU7726094A (en) 1994-09-02 1996-03-27 Immulogic Pharmaceutical Corporation Peptide compositions capable of down regulating an antigen specific immune response
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
EP0817854A2 (en) 1995-03-31 1998-01-14 Wolf, Hans, Prof. Dr. Antigen presentation system based on retrovirus-like particles
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
WO1999030736A2 (en) * 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) * 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
AU770802B2 (en) * 1998-10-21 2004-03-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Virus-like particles for the induction of autoantibodies
CN1193791C (zh) * 1998-11-30 2005-03-23 希托斯生物技术股份公司 抗原的有序分子呈递,制备及使用的方法
TR200200797T2 (tr) 1999-09-25 2002-10-21 University Of Iowa Research Foundation İmmünostimülatör nükleik asitler
WO2001085208A2 (en) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
ES2317955T3 (es) 2000-11-16 2009-05-01 Alk-Abello A/S Alergenos mutantes.
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
ATE347376T1 (de) * 2000-12-28 2006-12-15 Biomay Prod & Handel Behandlung von allergien
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
CA2441476A1 (en) 2001-03-02 2002-09-12 Alk-Abello A/S Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
AU2002347404A1 (en) 2001-09-14 2003-04-01 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
ES2320638T3 (es) * 2001-11-07 2009-05-27 Cytos Biotechnology Ag Disposicion ordenada de antigenos il-5, il-13 o eotasina, para el tratamiento de enfermedades alergicas con un componente eosinofilico.
KR20050044314A (ko) * 2001-11-07 2005-05-12 사이토스 바이오테크놀로지 아게 뼈 질환 치료용 항원 어레이
AU2003246690B2 (en) * 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
US20040076645A1 (en) 2002-07-19 2004-04-22 Bachmann Martin F. Ghrelin-carrier conjugates
EP1530585A2 (en) * 2002-08-22 2005-05-18 Cytos Biotechnology AG Inducible alphaviral/orip based gene expression system
AU2003275941A1 (en) 2002-11-01 2004-05-25 Alk-Abello A/S Recombinant protein variants
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
JP5022028B2 (ja) * 2003-03-26 2012-09-12 サイトス・バイオテクノロジー・アクチェンゲゼルシャフト メラン−ａペプチドアナログ−ウイルス様粒子コンジュゲート
WO2004094639A2 (en) 2003-04-24 2004-11-04 Im Vision Gmbh Recombinant fel d 1 allergen
CN100404070C (zh) * 2003-07-10 2008-07-23 赛托斯生物技术公司 包装的病毒样颗粒
US7767212B2 (en) * 2005-03-18 2010-08-03 Cytos Biotechnology Ag CAT allergen conjugates and uses thereof

Similar Documents

Publication Publication Date Title
JP2008535800A5 (enExample)
Jennings et al. The coming of age of virus-like particle vaccines.
JP5084103B2 (ja) ハプテン担体抱合体およびその用法
JP2014521684A5 (enExample)
JP2004522736A5 (enExample)
JP2008529558A5 (enExample)
RU2007138265A (ru) Белки, слитые с кошачьим аллергеном, и их применение
JP2008517975A (ja) 胃酸分泌抑制ポリペプチド（ｇｉｐ）抗原アッセイ及びその使用
JP2009510025A5 (enExample)
JP2008523132A (ja) Ｉｌ−１５抗原アレイとその使用法
ES2320638T3 (es) Disposicion ordenada de antigenos il-5, il-13 o eotasina, para el tratamiento de enfermedades alergicas con un componente eosinofilico.
MXPA04011247A (es) Conjugados portadores de grelina.
JP2006504653A5 (enExample)
JP2008530245A5 (enExample)
JP2016512213A5 (enExample)
JP2006516116A5 (enExample)
JP2011521662A5 (enExample)
JP2016521539A (ja) マラリアワクチン
EP3049107A1 (en) Self-assembled nanoparticle vaccines
JP2015509707A5 (enExample)
CN112292391A (zh) 用与细胞因子连接的ecm亲和肽治疗癌症的方法和组合物
JP2009520758A5 (enExample)
JP2010508857A5 (enExample)
JP2010538619A5 (enExample)
JP2010506926A5 (enExample)